50 / 164
50
ESTRO SCHOOL
TARGET GROUP
The course is aimed at radiation oncologists, urologists,
medical oncologists and other specialists and trainees
who have a special interest in prostate cancer and are
willing to update their knowledge.
COURSE AIM
This 5-day teaching course aims at focusing on the
management of localised, locally advanced and meta-
static prostate cancer. It emphasises the importance of
a multidisciplinary approach and teamwork, where full
information exchange is vital to provide the best up-
to-date scientific evidence on which the management
of the disease will be based. This will be illustrated
during state-of-the-art lectures presented by experts
in the field, covering important issues such as biology,
imaging, pathology, therapy and future developments.
Interactive case studies and journal clubs will be in-
tegrated on a daily basis and there will be ample time
for open discussions amongst participants and experts.
A special session on target delineation for radiation
oncologists will also be organised during the course.
LEARNINGOUTCOMES
• To provide an in-depth overview of the epidemiology,
pathology, imaging and treatment options for low,
intermediate and high risk prostate cancer
• To discuss patient selection/indications and con-
tra-indications for the various treatment options
• To provide a critical overview of the surgical and
radiotherapy techniques available for themanagement
of prostate cancer
• To discuss the new drugs currently available for the
management of the advanced and metastatic stages
of the disease
• To debate on the most recent developments relevant
to prostate cancer management.
COURSE CONTENT
Sunday 21 May 2017
• Normal prostate: anatomy – embryology, histology
• Prostate cancer: epidemiology and prevention, clinical
diagnosis, imaging modalities pathology, staging
• Case discussions.
Monday 22 May 2017
• Low risk prostate cancer: active surveillance, surgery
and the post-op pathology
• Radiotherapy and brachytherapy, the pathology after
irradiation
• External beam radiotherapy: on-line control, target
delineation
• Case discussions.
Tuesday 23 May 2017
• High risk prostate cancer: radiotherapy and hormones,
alternative radiotherapy regimens
• Toxicity of radiotherapy: acute and late morbidity –
erectile dysfunction
• Role of surgery and its morbidity
• Alternative treatments
• Case discussions and Journal Club.
Wednesday 24 May 2017
• Adjuvant and salvage radiotherapy after radical
surgery
• Rising PSA after surgery and after radiotherapy
• Imaging for recurrent detection
• Node positive prostate cancer
• Case discussions and Journal Club.
Thursday 25 May 2017
• Metastatic prostate cancer: hormones and their
complications
• Castration resistant prostate cancer: new drugs
• Palliative radiotherapy and surgery
• Non systemic treatment in the metastatic setting.
PREREQUISITES
Before commencing this course participants should:
• Revise the general principles of prostate cancer epi-
demiology, pathology, diagnosis and staging
• Read the published ESTRO and ASTRO guidelines
on prostate contouring and the EAU (European As-
sociation of Urology) guidelines on prostate cancer
Multidisciplinary Management of Prostate Cancer
21-25 May 2017
Porto, Portugal